Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jolanta Małyszko

Showing results (1-10 of 237) with videos related to

Pageof 24
Sort By:
Polskie Archiwum Medycyny Wewnetrznej|April 15, 2008
Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with essential arterial hypertensionJolanta Małyszko, Justyna Tymcio
Renal Failure|July 6, 2022
Acid-base balance in hemodialysis patients in everyday practiceMonika Wieliczko, Jolanta Małyszko
Advances in Medical Sciences|August 3, 2015
Copeptin: Pathophysiology and potential clinical impactEwelina Łukaszyk, Jolanta Małyszko
Przeglad Lekarski|July 15, 2014
[Iron and inflammation in renal diseases]Ewelina Łukaszyk, Jolanta Małyszko
Renal Failure|October 11, 2024
Continuous glucose monitoring (Dexcom g6) in people with diabetes after kidney transplantationZuzanna Jakubowska, Jolanta Małyszko
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|December 21, 2019
Treatment of hepatitis C in selected clinical settingsUrszula Ołdakowska-Jedynak, Jolanta Małyszko
Polish Archives of Internal Medicine|May 20, 2020
Acute kidney injury, its definition, and treatment in adults: guidelines and realityJoanna Matuszkiewicz-Rowińska, Jolanta Małyszko
Przeglad Lekarski|July 11, 2002
[Disorders of bone metabolism after renal transplantation]Edyta Zbroch, Jolanta Małyszko, Michał Myśliwiec
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|November 5, 2020
CANCER IN DIALYSIS PATIENTSMonika Wieliczko, Michał Pyrża, Jolanta Małyszko
International Journal of Molecular Sciences|October 14, 2023
Proenkephalin Levels and Its Determinants in Patients with End-Stage Kidney Disease Treated with Hemodialysis and Peritoneal DialysisWiktoria Grycuk, Zuzanna Jakubowska, Jolanta Małyszko
Pageof 24

Showing results (1-10 of 237) with videos related to

Sort By:
Pageof 24
Polskie Archiwum Medycyny Wewnetrznej|April 15, 2008
Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with essential arterial hypertensionJolanta Małyszko, Justyna Tymcio
Renal Failure|July 6, 2022
Acid-base balance in hemodialysis patients in everyday practiceMonika Wieliczko, Jolanta Małyszko
Advances in Medical Sciences|August 3, 2015
Copeptin: Pathophysiology and potential clinical impactEwelina Łukaszyk, Jolanta Małyszko
Przeglad Lekarski|July 15, 2014
[Iron and inflammation in renal diseases]Ewelina Łukaszyk, Jolanta Małyszko
Renal Failure|October 11, 2024
Continuous glucose monitoring (Dexcom g6) in people with diabetes after kidney transplantationZuzanna Jakubowska, Jolanta Małyszko
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|December 21, 2019
Treatment of hepatitis C in selected clinical settingsUrszula Ołdakowska-Jedynak, Jolanta Małyszko
Polish Archives of Internal Medicine|May 20, 2020
Acute kidney injury, its definition, and treatment in adults: guidelines and realityJoanna Matuszkiewicz-Rowińska, Jolanta Małyszko
Przeglad Lekarski|July 11, 2002
[Disorders of bone metabolism after renal transplantation]Edyta Zbroch, Jolanta Małyszko, Michał Myśliwiec
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|November 5, 2020
CANCER IN DIALYSIS PATIENTSMonika Wieliczko, Michał Pyrża, Jolanta Małyszko
International Journal of Molecular Sciences|October 14, 2023
Proenkephalin Levels and Its Determinants in Patients with End-Stage Kidney Disease Treated with Hemodialysis and Peritoneal DialysisWiktoria Grycuk, Zuzanna Jakubowska, Jolanta Małyszko
Pageof 24